210 related articles for article (PubMed ID: 10896863)
1. Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade.
Hagan MM; Rushing PA; Pritchard LM; Schwartz MW; Strack AM; Van Der Ploeg LH; Woods SC; Seeley RJ
Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R47-52. PubMed ID: 10896863
[TBL] [Abstract][Full Text] [Related]
2. Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor.
Kim MS; Rossi M; Abbott CR; AlAhmed SH; Smith DM; Bloom SR
Peptides; 2002 Jun; 23(6):1069-76. PubMed ID: 12126733
[TBL] [Abstract][Full Text] [Related]
3. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo.
Rossi M; Kim MS; Morgan DG; Small CJ; Edwards CM; Sunter D; Abusnana S; Goldstone AP; Russell SH; Stanley SA; Smith DM; Yagaloff K; Ghatei MA; Bloom SR
Endocrinology; 1998 Oct; 139(10):4428-31. PubMed ID: 9751529
[TBL] [Abstract][Full Text] [Related]
4. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
5. The role of the melanocortin system and the melanocortin-4 receptor in ring dove (Streptopelia risoria) feeding behavior.
Strader AD; Schiöth HB; Buntin JD
Brain Res; 2003 Jan; 960(1-2):112-21. PubMed ID: 12505663
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice.
Tolle V; Low MJ
Diabetes; 2008 Jan; 57(1):86-94. PubMed ID: 17909095
[TBL] [Abstract][Full Text] [Related]
7. Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII.
Clegg DJ; Benoit SC; Air EL; Jackman A; Tso P; D'Alessio D; Woods SC; Seeley RJ
Endocrinology; 2003 Jul; 144(7):2941-6. PubMed ID: 12810549
[TBL] [Abstract][Full Text] [Related]
8. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist.
Skuladottir GV; Jonsson L; Skarphedinsson JO; Mutulis F; Muceniece R; Raine A; Mutule I; Helgason J; Prusis P; Wikberg JE; Schiöth HB
Br J Pharmacol; 1999 Jan; 126(1):27-34. PubMed ID: 10051117
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonism gains weight.
Adan RA; Kas MJ
Trends Pharmacol Sci; 2003 Jun; 24(6):315-21. PubMed ID: 12823958
[TBL] [Abstract][Full Text] [Related]
10. Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice.
Adank DN; Lunzer MM; Lensing CJ; Wilber SL; Gancarz AM; Haskell-Luevano C
ACS Chem Neurosci; 2018 Feb; 9(2):320-327. PubMed ID: 28968061
[TBL] [Abstract][Full Text] [Related]
11. Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins.
Li YZ; Davidowa H
J Neurosci Res; 2004 Aug; 77(4):596-602. PubMed ID: 15264229
[TBL] [Abstract][Full Text] [Related]
12. Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats.
Polidori C; Geary N; Massi M
Peptides; 2006 Jan; 27(1):144-9. PubMed ID: 16198024
[TBL] [Abstract][Full Text] [Related]
13. Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat.
Edwards CM; Abbott CR; Sunter D; Kim M; Dakin CL; Murphy KG; Abusnana S; Taheri S; Rossi M; Bloom SR
Brain Res; 2000 Jun; 866(1-2):128-34. PubMed ID: 10825488
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection.
Hagan MM; Rushing PA; Benoit SC; Woods SC; Seeley RJ
Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R814-21. PubMed ID: 11171662
[TBL] [Abstract][Full Text] [Related]
15. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight.
Grill HJ; Ginsberg AB; Seeley RJ; Kaplan JM
J Neurosci; 1998 Dec; 18(23):10128-35. PubMed ID: 9822766
[TBL] [Abstract][Full Text] [Related]
16. Estradiol treatment fails to affect the feeding responses to melanocortin-3/4 receptor agonism or antagonism in ovariectomized rats.
Polidori C; Geary N
Peptides; 2002 Sep; 23(9):1697-700. PubMed ID: 12217431
[TBL] [Abstract][Full Text] [Related]
17. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
[TBL] [Abstract][Full Text] [Related]
18. Agouti-related peptide prevents steroid-induced luteinizing hormone and prolactin surges in female rats.
Schioth HB; Kakizaki Y; Kohsaka A; Suda T; Watanobe H
Neuroreport; 2001 Mar; 12(4):687-90. PubMed ID: 11277564
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-3 modulates food intake by interacting with the melanocortin/AgRP pathway.
Reizes O; Benoit SC; Strader AD; Clegg DJ; Akunuru S; Seeley RJ
Ann N Y Acad Sci; 2003 Jun; 994():66-73. PubMed ID: 12851299
[TBL] [Abstract][Full Text] [Related]
20. Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland.
Dhillo WS; Small CJ; Gardiner JV; Bewick GA; Whitworth EJ; Jethwa PH; Seal LJ; Ghatei MA; Hinson JP; Bloom SR
Biochem Biophys Res Commun; 2003 Jan; 301(1):102-7. PubMed ID: 12535647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]